Our Pricing

Wegovy Maintenance Dose After Reaching Goal Weight

Published on: June 03, 2026

Understanding the optimal wegovy maintenance dose after goal weight is crucial for sustaining your weight loss achievements long-term. At Cured Pharmacy, our UK-registered clinical team provides personalised maintenance strategies, helping you transition from active weight loss to sustainable weight management with Wegovy from £79.00.

Understanding Wegovy Maintenance Dosing After Reaching Your Goal Weight

Once you've achieved your target weight with Wegovy (semaglutide), the question of maintenance dosing becomes paramount. Clinical evidence from the STEP trials demonstrates that continuing semaglutide treatment is essential for sustained weight maintenance, with participants who discontinued treatment regaining approximately two-thirds of their lost weight within one year [1].

The standard maintenance dose of Wegovy is typically 2.4mg once weekly, which represents the maximum therapeutic dose used in clinical trials [1]. However, some patients may maintain their weight successfully on lower doses such as 1.7mg weekly, particularly if they experience persistent side effects or have achieved significant lifestyle modifications. Your UK prescriber will assess your individual response, tolerability, and weight stability when determining your optimal maintenance strategy.

It's important to recognise that Wegovy works by mimicking GLP-1, a natural hormone that regulates appetite and food intake. Maintaining therapeutic levels of semaglutide helps preserve the metabolic adaptations achieved during weight loss, including reduced hunger signals and improved satiety after meals [2]. Subject to prescriber approval, most patients continue on their final escalation dose indefinitely to prevent weight regain.

Clinical Evidence for Long-Term Wegovy Maintenance

The STEP 4 trial specifically examined weight maintenance with semaglutide, randomising participants who had already lost weight on 2.4mg weekly to either continue treatment or switch to placebo. Those who continued semaglutide maintained an average 17.4% total body weight loss, whilst the placebo group regained an average 6.9% of their body weight over 48 weeks [1].

This landmark study established that semaglutide is not merely a short-term weight loss tool but a long-term weight management medication. UK prescribers now routinely discuss maintenance therapy at the outset of treatment, setting realistic expectations about the likely need for ongoing medication to sustain results.

Wegovy Maintenance Dose Options and Personalisation Strategies

Whilst 2.4mg weekly remains the standard maintenance dose validated in clinical trials, UK prescribers may tailor your maintenance regimen based on several factors. Patients who experience persistent nausea, fatigue, or gastrointestinal symptoms on the maximum dose may achieve satisfactory weight maintenance on 1.7mg or even 1.0mg weekly, particularly if they've successfully implemented sustainable dietary and exercise habits [2].

Some prescribers adopt a 'step-down' approach, gradually reducing the dose after 3-6 months of weight stability to identify the minimum effective maintenance dose. This strategy can help minimise side effects and potentially reduce treatment costs, though it requires close monitoring to detect early signs of weight regain. Any dose reduction should be discussed with your UK prescriber and implemented gradually over several weeks.

Alternatively, patients who struggle to maintain their goal weight on lower doses may require the full 2.4mg weekly dose indefinitely. Clinical experience suggests that individuals with higher baseline BMI, significant metabolic dysfunction, or strong genetic predisposition to obesity often need maximum-dose maintenance to prevent relapse [3].

Preventing Weight Regain: Beyond Medication Alone

Whilst Wegovy maintenance dosing provides crucial pharmacological support, sustainable weight management requires a comprehensive lifestyle approach. The most successful patients combine ongoing semaglutide treatment with permanent behavioural modifications, including structured meal planning, regular physical activity, and psychological support where needed [3].

Research demonstrates that patients who engage in at least 150 minutes of moderate-intensity exercise weekly whilst on maintenance semaglutide achieve superior long-term outcomes compared to those relying on medication alone. Resistance training is particularly valuable, as it helps preserve lean muscle mass that may be lost during the weight loss phase, thereby maintaining metabolic rate [4].

Regular monitoring is essential during the maintenance phase. UK prescribers typically recommend monthly weight checks for the first three months after reaching your goal weight, then quarterly reviews thereafter. This allows early detection of weight regain (defined as 3-5% increase from goal weight) and prompt intervention through dose adjustment, lifestyle review, or additional support services.

Psychological Aspects of Weight Maintenance

The transition from active weight loss to maintenance represents a significant psychological shift. Many patients report feeling less motivated once they've achieved their goal, or experience anxiety about potential regain. Acknowledging these challenges and developing coping strategies is crucial for long-term success.

Consider working with a registered dietitian or behavioural therapist who specialises in weight management. They can help you develop sustainable eating patterns, address emotional eating triggers, and build resilience against the inevitable weight fluctuations that occur even with optimal medication adherence.

What Happens If You Stop Wegovy After Reaching Goal Weight?

Discontinuing Wegovy after achieving your target weight typically results in significant weight regain, as demonstrated conclusively in the STEP 4 withdrawal trial [1]. Within 12 months of stopping treatment, most patients regain approximately 60-70% of their lost weight, with some individuals returning to their pre-treatment weight or higher.

This phenomenon occurs because semaglutide doesn't 'cure' the underlying biological drivers of obesity. When you stop treatment, the hormonal signals that promote hunger and reduce satiety return to their pre-treatment levels, often accompanied by metabolic adaptations that favour weight regain. Your body essentially 'defends' against the weight loss, increasing appetite and reducing energy expenditure [2].

For this reason, UK prescribers now frame Wegovy as a long-term weight management medication rather than a temporary intervention. If you're considering stopping treatment due to side effects, cost concerns, or other factors, discuss alternative strategies with your prescriber first. Options may include dose reduction, temporary treatment breaks with close monitoring, or switching to an alternative medication such as Mounjaro or Saxenda.

Wegovy Maintenance Dose Compared to Alternative Weight Loss Medications

When considering long-term maintenance strategies, it's worth understanding how Wegovy compares to other UK-licensed weight management medications. Mounjaro (tirzepatide), a dual GIP/GLP-1 receptor agonist, has demonstrated even greater weight loss in clinical trials, with average reductions of 22.5% at the highest dose compared to semaglutide's 14.9% [5]. Some patients transition to Mounjaro for maintenance if they experience weight regain on Wegovy.

Saxenda (liraglutide) represents an earlier-generation GLP-1 medication requiring daily injections rather than weekly administration. Whilst effective for weight maintenance in some patients, the daily injection burden and generally lower efficacy make it less popular for long-term use. However, at Cured Pharmacy, Saxenda is available as a lower-cost alternative for patients who respond well to GLP-1 therapy but find weekly injections inconvenient.

Oral medications such as Orlistat and Mysimba work through entirely different mechanisms and may be considered as adjunct therapy during Wegovy maintenance, though evidence for combination approaches remains limited. Your UK prescriber can assess whether adding a complementary treatment might enhance your maintenance outcomes, subject to clinical suitability and potential drug interactions.

Switching Between Weight Loss Medications During Maintenance

Some patients benefit from switching medications during the maintenance phase, either due to tolerability issues, cost considerations, or inadequate weight control. Transitioning from Wegovy to Mounjaro, for example, requires careful dose conversion and monitoring, as the two medications have different potencies and dosing schedules.

Any medication switch should be supervised by a UK prescriber who can provide guidance on appropriate washout periods, initial dosing, and monitoring for adverse effects. At Cured Pharmacy, our clinical team can facilitate seamless transitions between weight management medications, ensuring continuity of care throughout your maintenance journey.

Accessing Wegovy Maintenance Prescriptions Through Cured Pharmacy

At Cured Pharmacy, we provide ongoing support for patients in the maintenance phase of their Wegovy treatment. Our UK-registered prescribers conduct regular clinical reviews to assess your weight stability, tolerability, and overall health status, ensuring your maintenance dose remains appropriate for your individual circumstances. Wegovy is available from £79.00 with transparent upfront pricing shown before your consultation.

Our streamlined online consultation process takes under three minutes and includes comprehensive assessment of your weight history, current medications, and any side effects you may be experiencing. This allows our clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), to provide personalised maintenance recommendations tailored to your needs.

We offer discreet packaging and convenient home delivery across the UK, with automatic prescription renewal reminders to ensure uninterrupted treatment. For patients requiring dose adjustments or experiencing challenges during maintenance, our clinical team is available for additional consultations at no extra charge. All medications dispensed are genuine UK-licensed products, sourced exclusively through regulated channels and subject to rigorous quality controls.

Scientific References

1. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Wadden, T. A., et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 325(14), 1403–1413. https://doi.org/10.1001/jama.2021.1831 [accessed 13 August 2026]
4. Lundgren, J. R., et al. (2021). Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. New England Journal of Medicine, 384(18), 1719–1730. https://doi.org/10.1056/NEJMoa2028198 [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.